Does Caffeine Shampoo Work for Hair Loss? What the Studies Actually Tested

Medically reviewed by our in-house trichology committee.

Almost every question I get about caffeine shampoo arrives in the same shape. Someone has been using it for a year or two, they aren’t sure anything has happened, and they want to know whether they’ve been throwing money at a gimmick.

The honest answer annoys both camps. This isn’t a gimmick — there is genuine published research behind caffeine and hair follicles, going back nearly twenty years. It also isn’t a treatment, and the reason has almost nothing to do with the molecule.

It has to do with the drain.

How caffeine got onto the shelf

Start in a German dermatology lab in 2007. Fischer, Hipler and Elsner took human scalp follicles, kept them alive in culture, and watched what testosterone did to them — then what happened when caffeine was added.

Testosterone suppressed growth in follicles taken from men with androgenetic alopecia. No surprise there. The interesting part came next: with caffeine in the medium, that suppression eased, and the hair shafts elongated more than in control medium alone.

Seven years later the same line of work went further. Writing in the British Journal of Dermatology, Fischer and colleagues tested both male and female follicles and found caffeine lengthened the shaft, extended the growth phase in culture, drove proliferation in the hair matrix, and shifted the balance of two signalling molecules known to regulate the hair cycle. Female follicles responded at lower concentrations than male ones.

That is a real mechanism, published in real journals, and it explains why the industry moved on it so fast.

It also describes a follicle sitting in caffeine continuously, around the clock. Which is precisely what a shampoo does not deliver.

💡 Thomas R.’s take: “Whenever someone hands me an in vitro study to justify a purchase, I ask the same thing: was that follicle in your situation? With caffeine the answer is no, and that isn’t pedantry. An active that works in culture and gets rinsed off thirty seconds later are two different subjects.”

Contact time: the detail that decides everything

Does caffeine even get through the scalp? Yes — that part is settled.

In 2007, a Berlin group led by Otberg published a neat experiment in Skin Pharmacology and Physiology. They applied a caffeine-containing shampoo formulation, left it on for two minutes, rinsed, and tracked the molecule in blood. By selectively blocking the follicular openings on one test area, they could separate what crossed through follicles from what crossed through the stratum corneum. Caffeine got through after two minutes of contact, and the follicular route contributed substantially — it was the faster of the two.

That study gets waved around as proof that shampoo is enough. It proves something narrower: the molecule crosses the barrier. Not that it reaches the follicle at the concentration, and for the duration, that produced an effect in culture. “It got in” and “it got in at a useful level, for long enough, often enough” are separated by the whole distance between proof of principle and proof of benefit.

Hold on to the number: two minutes. That is the contact time the penetration work rests on, and it is not what happens in an average shower, where shampoo sits on the scalp for twenty or thirty seconds before it goes down the drain. Buy the bottle, rinse it straight off, and you are not replicating anything. You are washing your hair.

The trial everyone quotes

There is a head-to-head clinical trial. It exists, it is real, and it is consistently misreported.

In 2017, in Skin Pharmacology and Physiology, Dhurat and colleagues published a multicentre non-inferiority study in 210 men with androgenetic alopecia. One arm got 5% minoxidil solution; the other got a caffeine-based topical liquid at 0.2%. The primary endpoint was the change in the proportion of anagen hairs on trichogram at six months.

The published figures: roughly 11.7% improvement in the anagen ratio on minoxidil, roughly 10.6% on caffeine. The authors concluded the caffeine liquid should be considered not inferior to 5% minoxidil.

Three things belong in the same breath as that headline.

The product tested was not a shampoo. It was a liquid that stays on the scalp. The entire result rests on a leave-on application — exactly what the section above predicted would matter.

The trial was open-label with no placebo arm. Nobody was blinded, not participants and not investigators. On a trichogram endpoint, in a condition where expectation is doing real work, no blinding and no placebo control is a serious limitation rather than a footnote.

Non-inferiority carries a hidden assumption. Showing that A matched B is only informative if you know B performed as expected in this particular trial. Without a placebo arm, you don’t.

None of that makes it junk. It makes it a published signal — encouraging, and not sufficient.

Nine studies, 684 people, graded

In February 2025, two researchers at Jagiellonian University in Kraków, Szendzielorz and Spiewak, published a systematic review in Healthcare covering the entire clinical literature on topical caffeine for hair loss. They screened 1,121 records and kept nine studies, covering 684 people between them.

Their first finding sounds like good news. All nine studies concluded in favour of topical caffeine. Not one reported failure.

Their second finding immediately reframes the first. They graded the level of evidence as medium in three studies, low in one, and very low in the remaining five. The recurring flaws: no randomisation, no placebo or control group, and — remarkable for a literature about an active ingredient — no information on how much caffeine the tested product actually contained.

Their conclusion comes in two halves, and both belong on the label: the published data suggest topical caffeine preparations are safe and effective against hair loss, and better-designed trials on products of defined composition are needed before anything can be settled.

Guess which half tends to survive the trip to a product page.

💡 Thomas R.’s take: “A literature where every study is positive and almost none has a control group isn’t the signature of a product that works. It’s the signature of a product nobody has seriously tried to disprove. The day someone runs a double-blind, placebo-controlled trial on a formulation whose concentration is disclosed, we’ll know. Until then, we’re assuming.”

When a regulator asked for the evidence

There is a blunt way to find out what a scientific file is worth: hand it to someone whose job is to attack it.

That happened in the UK. In March 2018, the Advertising Standards Authority examined an ad for a caffeine shampoo claiming it “can actually help to reduce hair loss.” The complaint came from a professional in the field. The manufacturer submitted its dossier — clinical studies, in vitro work, a consumer satisfaction survey.

The ASA went through it and was not persuaded: studies without a control group, work done in vitro rather than in people, and trials run only in men with androgenetic alopecia while the claim was addressed to everyone. Its published conclusion was that the claim had not been substantiated and was therefore misleading. The ad was banned from appearing again, and the brand was told not to state or imply that its product could reduce hair loss unless it held adequate evidence.

One clarification, because this gets misread constantly: the ruling does not say caffeine does nothing. It says that on inspection, the file did not support the sentence printed on the poster. That distinction matters, and it applies to the whole category.

There is a structural reason behind it. Shampoo is a cosmetic, not a drug. It never had to demonstrate therapeutic efficacy before going on sale, and it is not entitled to claim it treats a disease. Ketoconazole shampoo exists in a medicated version as well, and the difference in status shows up immediately in what each is allowed to print on the bottle.

Quick test: shampoo, leave-in, or neither?

Three questions. Of the five outcomes, two point to a product and three send you somewhere else — which is roughly the split I see in practice.

What it can reasonably do for you

Drop the yes-or-no framing. Caffeine shampoo is neither a scam nor a treatment, and it has a genuine place once you define it correctly.

It washes your hair, reliably. Less trivial than it sounds. A clean, un-irritated scalp free of buildup tolerates topicals better. Plenty of people quit minoxidil over itching and flaking that a decent wash routine would have handled.

It thickens the look of the fibre. These formulas usually pair caffeine with film-forming agents that coat and swell the shaft. The effect is cosmetic, immediate, and gone after the next wash. That isn’t regrowth — and it can still make the next few months easier to live with while something slower does the real work.

It might do something at the follicle. A hypothesis, not a promise. The mechanism exists, penetration is demonstrated, the clinical evidence is weak. If you buy it, buy it knowing where the file stands, and let the manufacturer’s contact time actually elapse instead of rinsing on reflex.

What it doesn’t do. It doesn’t substitute for a documented treatment in active androgenetic alopecia, it doesn’t restart a follicle that has been gone for years, and it doesn’t excuse you from finding the cause of recent diffuse shedding.

Limits, tolerance, and when to see a doctor

Caffeine on the scalp is well tolerated, and the 2025 review flagged no worrying safety signal across the studies it collected. The risk with this product isn’t dermatological. It’s strategic: it’s the time you give it.

A few markers I repeat often:

• A cosmetic doesn’t make a diagnosis. Androgenetic alopecia, telogen effluvium, alopecia areata and iron deficiency look alike from across the room and are managed completely differently. Twelve months of shampoo is twelve months of not knowing which one you have.
• Don’t swap a prescribed treatment for a shampoo. Adding, dropping or changing a treatment belongs to whoever prescribed it. Finasteride is a prescription-only medicine with side effects worth understanding and an absolute contraindication in pregnancy. Minoxidil is a medicine too, with its own effects and its own early shedding phase.
• A scalp that itches, reddens or flakes isn’t a caffeine problem and won’t be fixed by switching brands. That’s a consultation, and often a simple answer.
• Pregnancy, breastfeeding, ongoing dermatological treatment, broken skin on the scalp: ask before you buy, not after.
• Judge on photographs, not on the mirror. Same framing, same light, same distance, three months apart. The morning mirror measures nothing.

Some signs belong to no shampoo and need a prompt opinion: sudden heavy shedding, sharply defined bald patches, a scalp that hurts or stays red, or associated symptoms — unusual fatigue, feeling cold, cycle changes, unexplained weight change. Those point toward alopecia areata, a thyroid disorder, a deficiency or a systemic illness, and they call for a primary care doctor, a dermatologist or an endocrinologist.

Frequently asked questions

Does caffeine shampoo regrow hair?

Nothing supports saying so. The mechanism in isolated follicles is real and penetration through the scalp is demonstrated, but the strongest clinical trial tested a leave-on liquid, and the 2025 systematic review graded the evidence low or very low in six of nine studies. A regulator has already forced the “helps reduce hair loss” claim off an ad for lack of adequate evidence.

How long should I leave it on?

Follow the time on the bottle — that’s the only contact time the product was formulated around. What the penetration work shows is that a few dozen seconds and a few minutes are not the same exposure. Rinsing immediately empties the gesture of whatever value it had.

Can I use it with minoxidil?

They’re two separate gestures, one washed off and one left on, and nothing suggests incompatibility. The thing to watch is scalp tolerance, not an interaction. If you’re on a prescribed treatment, put the question to the clinician who started it rather than to a forum.

Shampoo or leave-in liquid — which one?

If you want to be closer to what was actually studied, the leave-on format is what the head-to-head trial used. The shampoo keeps its role as a daily wash and for scalp comfort. They do different jobs and don’t replace each other.

Does it work for women?

The isolated-follicle work included female follicles, and they responded at lower concentrations. But the available clinical data is overwhelmingly in men with androgenetic alopecia — that was one of the regulator’s specific criticisms. In women, shedding deserves a search for the cause first, iron and thyroid at the top of the list.

Why is it everywhere if the evidence is this thin?

Because a cosmetic reaches the market without a prior efficacy demonstration, unlike a drug. That isn’t fraud, it’s a different regulatory frame — and it’s exactly what the UK regulator underlined in 2018 when it demanded evidence for a sentence, not for a product.

Sources and references

1. Fischer T.W., Hipler U.C., Elsner P. — Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro — International Journal of Dermatology, 2007;46(1):27-35. PubMed

2. Fischer T.W., Herczeg-Lisztes E., Funk W., Zillikens D., Bíró T., Paus R. — Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and TGF-β2/IGF-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro — British Journal of Dermatology, 2014;171(5):1031-1043. DOI

3. Otberg N., Teichmann A., Rasuljev U., Sinkgraven R., Sterry W., Lademann J. — Follicular Penetration of Topically Applied Caffeine via a Shampoo Formulation — Skin Pharmacology and Physiology, 2007;20(4):195-198. PubMed

4. Dhurat R., Chitallia J., May T.W. et al. — An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia — Skin Pharmacology and Physiology, 2017;30(6):298-305. PubMed

5. Szendzielorz E., Spiewak R. — Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence — Healthcare (Basel), 2025;13(4):395. PubMed

6. Szendzielorz E., Spiewak R. — Caffeine as an Active Molecule in Cosmetic Products for Hair Loss: Its Mechanisms of Action in the Context of Hair Physiology and Pathology — Molecules, 2025;30(1):167. DOI

7. Advertising Standards Authority (UK) — ASA Ruling on Dr Kurt Wolff GmbH & Co KG, 28 March 2018. ASA

---

Scientifically validated by our committee of trichology experts. This article does not replace a medical consultation.